A risk genotype (AA) at the V175M variant (rs7946) in PEMT, which results in a partial loss of PEMT activity, was 1.7-fold higher in individuals with NAFLD compared to normal controls [112]. This evidence concerns the gene PEMT and metabolic dysfunction-associated steatotic liver disease.